What does CUSIP 501575104 represent in this 13F holders report?

CUSIP 501575104 is the security identifier for KYMR - Kymera Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KYMR - Kymera Therapeutics, Inc. - Common Stock in Q2 2023?

124 institutional investors reported KYMR - Kymera Therapeutics, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Kymera Therapeutics, Inc. - Common Stock (KYMR)

CUSIP: 501575104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 80,235,145
Total 13F shares: 58,230,116
Share change: +1,560,147
Total reported value: $1,338,678,295
Put/Call ratio: 46%
Price per share: $22.99
Number of holders: 124
Value change: +$29,100,921
Number of buys: 66
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 501575104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Atlas Venture Life Science Advisors, LLC	13F	Company	7.3%	5,858,262	$173,580,303	—	31 Mar 2023	13F
ATLAS VENTURE ASSOCIATES X, L.P.	3/4/5	10%+ Owner	— class O/S missing	5,763,012	$173,161,222	—	11 Aug 2021	3/4/5
BVF INC/IL	13F	Company	5.9%	4,739,004	$140,416,689	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	5.8%	4,666,681	$138,275,000	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.3%	4,291,018	$127,142,862	—	31 Mar 2023	13F
Avoro Capital Advisors LLC	13F	Company	4.8%	3,855,000	$114,223,650	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4.7%	3,733,925	$110,636,198	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	4.2%	3,330,190	$98,673,530	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	3.6%	2,879,825	$85,329,215	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	3.4%	2,726,825	$80,795,825	—	31 Mar 2023	13F
Redmile Group, LLC	13F	Company	3%	2,410,769	$71,431,085	—	31 Mar 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	2.5%	1,968,175	$58,318,000	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	2.3%	1,805,346	$53,492,000	—	31 Mar 2023	13F
Rock Springs Capital Management LP	13F	Company	1.5%	1,228,379	$36,396,870	—	31 Mar 2023	13F
WASATCH ADVISORS LP	13F	Company	1.3%	1,037,414	$30,738,577	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	1.2%	965,967	$28,621,615	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	0.99%	796,093	$23,588,236	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.97%	780,829	$23,135,973	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.92%	739,991	$21,924,860	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.83%	667,351	$19,773,615	—	31 Mar 2023	13F
Deer Management Co. LLC	13F	Company	0.77%	615,895	$18,248,969	—	31 Mar 2023	13F
Aquilo Capital Management, LLC	13F	Company	0.75%	601,325	$17,817,260	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.71%	566,966	$16,799,000	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.64%	511,476	$13,949,183	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.45%	359,928	$10,664,666	—	31 Mar 2023	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.42%	339,147	$10,048,926	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.42%	336,827	$9,980,184	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.41%	326,322	$9,668,921	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.37%	298,497	$8,844,466	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.37%	296,843	$8,795,458	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.34%	276,788	$8,201,228	—	31 Mar 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.31%	251,361	$7,447,826	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.3%	242,512	$7,185,631	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.26%	209,089	$6,195,307	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.26%	204,731	$6,066,180	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.25%	202,100	$5,988,223	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.24%	189,486	$5,614,470	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.23%	185,295	$5,490,290	—	31 Mar 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.22%	176,528	$5,230,526	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.21%	167,536	$4,964,092	—	31 Mar 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.14%	115,042	$3,395,463	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	114,401	$3,389,000	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.12%	100,010	$2,963,296	—	31 Mar 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.12%	94,015	$2,785,664	—	31 Mar 2023	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.11%	89,496	$2,651,766	—	31 Mar 2023	13F
Jefferies Financial Group Inc.	13F	Company	0.11%	84,492	$2,503,498	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.1%	77,000	$2,281,510	—	31 Mar 2023	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.09%	75,941	$2,250,132	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	72,677	$2,153,420	—	31 Mar 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.09%	72,096	$2,136,204	—	31 Mar 2023	13F

Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q2 2023

As of 30 Jun 2023, Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,230,116 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, and Redmile Group, LLC. This page lists 124 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

123

Q2 2023 holders

124

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.